Gerresheimer Releases 2025 Stable Revenue Amidst Challenges

Gerresheimer AG revealed its 2025 financial statements, recording revenue of EUR 2.3 billion and an adjusted EBITDA of EUR 384 million. The company reported a slight organic revenue growth of 0.3%, despite a challenging market. This result was driven by the Plastics & Devices division's strong performance in drug delivery devices.

The Primary Packaging Glass division faced decreased demand for cosmetics and pharmaceutical packaging, leading to a decline in revenue compared to the previous year. Adjusted EBITDA margin for Gerresheimer stood at 16.8%, impacted by currency adjustments.

For 2026, Gerresheimer expects revenues to remain between EUR 2.3 and 2.4 billion, with improved EBITDA margins. Additionally, the company plans to finalize the sale of its subsidiary, Centor, and pursue debt refinancing to enhance its financial stability.

Gerresheimer's continued focus is on transparency and compliance, with measures in place to improve its financial management and operational efficiencies. Internal investigations have prompted necessary corrections in revenue and accounting practices for prior years.